EU Pharma Legislation Overhaul To Lower IP Protection, Warns Industry

 
• By Francesca Bruce

European Commission plans for an overhaul of the pharmaceutical legislation would halve market protection for orphan drugs and risk the predictability of the regulatory system, warns industry expert.

Competition runners
Planned IP protection reforms threaten competitiveness of EU Pharma Industry • Source: Shutterstock

More from Europe

More from Geography